Effects of Regular Exercise on Adult Asthma
1 other identifier
interventional
131
1 country
1
Brief Summary
The purpose of this study is to assess the effects of regular exercise on physical fitness, asthma control, and quality of life among adult asthmatics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started Aug 2011
Longer than P75 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 30, 2013
CompletedFirst Posted
Study publicly available on registry
December 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2015
CompletedMay 11, 2017
May 1, 2017
3.9 years
May 30, 2013
May 10, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma control
Asthma control based on symptom score and PEF-values
6-month period
Secondary Outcomes (1)
Physical fitness
Baseline and 6 months
Other Outcomes (4)
Lung function
Baseline and 6 months
Quality of Life
Baseline and 6 months
Step test
Baseline and 6 months
- +1 more other outcomes
Study Arms (2)
Intervention group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
The exercise group is given a 24-week individualized training program, including aerobic exercise, muscular training, relaxation exercises and stretching. Patients are asked to observe their asthma control daily and to mark in their diary asthma symptoms and activity limitations as well as duration, intensity and form of exercising on daily basis. They are also asked to perform PEF-measurements twice a day for one-week period every 4 weeks. The control group receives ordinary instructions.
Eligibility Criteria
You may qualify if:
- diagnosis of asthma made by physician, or reimbursement for asthma medication from the National Social Insurance Institution of Finland (code 203), or patient fulfills the diagnostic criteria for asthma as outlined in the Finnish Guidelines for Asthma Management (Käypä hoito -suositus 2006 and 2012)
You may not qualify if:
- FEV1 \< 60 % of predicted in spirometry
- PEF variability \> 30 % at least 2 times during a 1-week monitoring period
- use of bronchodilating medication at least 4 times daily
- permanent, daily steroid tablet treatment
- patients who exercise regularly already at baseline at least 3 times a week at least 30 min at a time
- serious coronary heart disease
- severe hypotension
- severe heart failure
- severe musculoskeletal disorder
- dementia
- physician-diagnosed chronic obstructive lung disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oululead
- GlaxoSmithKlinecollaborator
- Foundation of the Finnish Anti-Tuberculosis Associationcollaborator
- Research Foundation of the Pulmonary Diseasescollaborator
- Jalmari and Rauha Ahokas Foundationcollaborator
- Vaino and Laina Kivi Foundationcollaborator
- Ida Montini Foundationcollaborator
- Oulu University Hospitalcollaborator
Study Sites (1)
Center for Environmental and Respiratory Health Research, University of Oulu
Oulu, 90014, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2013
First Posted
December 16, 2013
Study Start
August 1, 2011
Primary Completion
June 30, 2015
Study Completion
June 30, 2015
Last Updated
May 11, 2017
Record last verified: 2017-05